1. Home
  2. IRON vs BHC Comparison

IRON vs BHC Comparison

Compare IRON & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

HOLD

Current Price

$66.38

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Logo Bausch Health Companies Inc.

BHC

Bausch Health Companies Inc.

HOLD

Current Price

$5.92

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
IRON
BHC
Founded
2017
N/A
Country
United States
Canada
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
2.5B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
IRON
BHC
Price
$66.38
$5.92
Analyst Decision
Strong Buy
Hold
Analyst Count
13
3
Target Price
$99.54
$8.33
AVG Volume (30 Days)
943.0K
1.9M
Earning Date
05-29-2026
05-18-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
423.08
EPS
N/A
0.42
Revenue
N/A
$8,724,000,000.00
Revenue This Year
N/A
$4.24
Revenue Next Year
$215.03
N/A
P/E Ratio
N/A
$14.08
Revenue Growth
N/A
N/A
52 Week Low
$30.82
$4.28
52 Week High
$99.50
$8.69

Technical Indicators

Market Signals
Indicator
IRON
BHC
Relative Strength Index (RSI) 43.58 43.74
Support Level $57.45 $5.89
Resistance Level $82.70 $6.32
Average True Range (ATR) 6.10 0.30
MACD 0.27 0.04
Stochastic Oscillator 73.52 50.00

Price Performance

Historical Comparison
IRON
BHC

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

About BHC Bausch Health Companies Inc.

Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.

Share on Social Networks: